Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

UPADACITINIB vs UROFOLLITROPIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

UPADACITINIB vs UROFOLLITROPIN: Safety Overview

Metric UPADACITINIB UROFOLLITROPIN
Total FAERS Reports 65,656 101
Deaths Reported 2,406 1
Death Rate 3.7% 1.0%
Hospitalizations 15,931 84
Average Patient Age 57.4 yrs 32.6 yrs
% Female Patients 71.2% 97.6%
FDA Approval Date Apr 26, 2024 N/A
Manufacturer AbbVie Inc. N/A
Route ORAL N/A
Marketing Status Prescription Discontinued